Drug Release Formulation

A category based upon the characteristics of release of active and/or inert ingredient(s).
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2016
01219862016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A new mineral-polymer composite (FCC-PCL) performance was assessed to produce complex geometries to aid in development of… (More)
Is this relevant?
2016
2016
The purpose of this study was to develop a pH-independent drug release formulation using lipocalin-type prostaglandin D synthase… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
The objective of this study was to develop and evaluate a press-coated pulsatile drug delivery system intended for treatment of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
The objective of this study was to develop and evaluate a press-coated pulsatile drug delivery system intended for treatment of… (More)
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
Review
2007
Review
2007
INTRODUCTION Amajor objective of the pharmaceutical industry is to develop drugs with good oral bioavailability. Administration… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2004
2004
Biodegradable poly D,L-lactic acid (PLA, molecular weight: ca. 5000) microcapsules containing a CXCR4 antagonist (4F-benzoyl… (More)
Is this relevant?
1986
1986
Luteinizing hormone-releasing hormone (LH X RH) agonist can be administered daily to patients with prostatic cancer with… (More)
Is this relevant?